Topic

Articles

The transaction is expected to close in the third quarter of 2023.

Eli Lilly Set to Acquire DICE Therapeutics 

Advanco’s acquisition of Vantage Consulting Group boosts its position as a provider of independent pharmaceutical serialization solutions.

Advanco Acquires Vantage Consulting Group

The investment, which is taking place in Hillerød, Denmark, will aim to create more production capacity and increase the company’s ability to meet future market demands and to continue development on its future clinical late-phase product portfolio.

Novo Nordisk to Expand Manufacturing Facilities in Hillerød, Denmark

The merger agreement states that Novartis will acquire all the shares of Chinook through a subsidiary for a price of $40 per share in cash at closing.

Chinook Therapeutics Acquired by Novartis AG

This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

New Velocity Vials Technology Platform to Expand Industry Partnerships

Feliza Mirasol is the science editor for 

Lonza will gain access to R&D capabilities, including payload and site-specific linker technology, through its acquisition of ADC company, Synaffix.

Lonza Acquires Synaffix in ADC Deal

Adamis Pharmaceuticals announced the closing of its merger with DMK Pharmaceuticals on May 25, 2023.

Adamis Pharmaceuticals Closes Merger with DMK Pharmaceuticals 

Through the acquisition, Avacta gains Coris’ product portfolio consisting of diagnostic tests for respiratory, gastroenteric, and blood-borne pathogens as well as for the detection of antibiotic resistance markers.

Avacta Acquires Coris BioConcept to Grow Diagnostics Product Portfolio

Under the new MTA and Option License Agreement, Adcendo can nominate ADCs against two novel ADC targets, according to the press release.

Adcendo and Duality Biologics in License Agreement to Expand ADC Pipeline

The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.

Mergers and Acquisitions